[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 10, Issue 2 (8-2017) ::
2017, 10(2): 37-52 Back to browse issues page
In silico design of recombinant IFNα/β receptor protein to combat antagonistic effects of Ebola VP35 protein
Yaser Ghazi * , Fatemeh Haddadi
MSc. Faculty of Sciences, Zabol of University, Iran
Abstract:   (4165 Views)
The VP35 protein in Ebola virus is one of the main pathogenic components interacting to host cells and interferes with natural cellular immune responses. This is done by antagonistic potential of the viral VP35 protein which inhibits interferon regulatory factor 3 (IRF-3) protein in the infected cells and then induction of antiviral genes expression are disrupted. In the present in silico study, we have designed a novel recombinant IFNα/β receptor protein which can be secreted out by host cells and circulate in blood stream. When the body encounters the virus, the recombinant protein can binds to VP35 and inhibit its antagonistic effect on IRF-3 proteins. Evaluations made by bioinformatics softwares revealed that the novel recombinant protein show promise for ameliorating the virulence of Ebola. But the obtained results should be investigated in vitro and in vivo for further evaluation and possible approval as a therapeutic strategy.  
Keywords: antagonistic, bioinformatics, Ebola virus, IFNα/β receptor, VP35 protein
Full-Text [PDF 1492 kb]   (3138 Downloads)    
Type of Study: Research | Subject: Special
Received: 2016/11/21 | Accepted: 2017/07/25 | Published: 2018/05/7
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

ghazi Y, haddadi F. In silico design of recombinant IFNα/β receptor protein to combat antagonistic effects of Ebola VP35 protein. Journal of Biosafety 2017; 10 (2) :37-52
URL: http://journalofbiosafety.ir/article-1-155-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 10, Issue 2 (8-2017) Back to browse issues page
فصل نامه علمی ایمنی زیستی Journal of Biosafety
Persian site map - English site map - Created in 0.07 seconds with 37 queries by YEKTAWEB 4645